BioSpace News Archive

Deals

Celgene Scoops Up San Diego Biotech in $7B Deal

The company said it will acquire Impact Biomedicines and its JAK inhibitor program targeting myelofibrosis.

January 7, 2018
·
2 min read
·
Alex Keown
Business

Pfizer to Cut 300 Jobs as It Ends Alzheimer’s, Parkinson’s Quest

About 200 of the job cuts will be in Massachusetts, the remaining in Connecticut.

January 7, 2018
·
3 min read
·
Mark Terry
Deals

Struggling Acorda is Exploring a Sale, Shares Jump

Rumors that Acorda was considering a sale drove company stock up about 12 percent on Friday, Jan. 5, to hit $23.55.

January 7, 2018
·
3 min read
·
Mark Terry
F1 Oncology Announces Development Milestone and $10M Equity Investment

The two conditionally active CAR-T cellular products targeting AXL and ROR2 will be tested in subjects with refractory, advanced stage mRCC.

January 7, 2018
·
3 min read
Business

F1 Oncology’s International Affiliates and Sinobioway Sunterra Biotech Announce New Development, Manufacturing, and Supply Agreements to Support cGMP Lentivirus Supply

The new facility, Shenzhen Biowit, which will expand from the current clinical production staff and site in Shenzhen, is scheduled for completion in 2018 and will utilize F1 Oncology’s chemically defined suspension-based lentivirus manufacturing technology and processes.

January 7, 2018
·
4 min read
Business

Ally Bridge Group and LifeTech Scientific Form China-Global Medtech Investment and Operating Partnership

The ABG-LifeTech partnership encompasses three key components.

January 7, 2018
·
3 min read
Business

San Diego Neurocrine’s CMO to Retire, Replacement Named

Christopher O’Brien, M.D., CMO, has notified the Company he plans to retire in February 2018, after a transition period with his successor.

January 7, 2018
·
6 min read
BioForest

All Eyes on Better Health at CES 2018: Innovation Awards Honoree RightEye Debuts EyeQ System

RightEye announced today it will be debuting its new RightEye EyeQ system tonight at CES Unveiled Las Vegas at 5:00 p.m. at the Mandalay Bay Shorelines Exhibit Hall in Las Vegas, Nevada.

January 7, 2018
·
5 min read
Deals

Celularity Scoops Up Alliqua BioMedical in $29M Deal

Alliqua BioMedical’s Board of Directors unanimously approved entering into the agreement.

January 7, 2018
·
6 min read
BioMidwest

Skyline Medical Announces Pricing of Firm Commitment Public Offering of Common Stock and Warrants

Dawson James Securities, Inc. is acting as the sole underwriter for the offering.

January 7, 2018
·
6 min read